BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
Emami Ltd.’s Q1 FY21 volume declined 28% as a large part of the portfolio is discretionary (within staples) in nature. Highlights as follows:
1. Strong performance in healthcare portfolio supported by new launches (approximately 5% of sales)
2. Sequential improvement in performance (8% growth in June, double-digit growth in July)
3. Secondary sales (down 15%) better than primary (down 26%)
4. Channel inventory correction to approximately 18 days from approximately 30 days (potential buffer for sales improvement in FY21)
5. Reduced the credit period offered to channel partners to approximately five days from approximately 14 days earlier
Consensus worries on promoter debt levels have largely been allayed (cement deal concluded, promoter pledge reduced to 55% from 90%, will further go down to 50% as per guidance), we expect the stock's discount to the sector to reduce from 67% currently.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.